NFKB1 and breast carcinoma: Riggins et al. demonstrated that pharmacologic inhibition of NF-κB by parthenolide, a small molecule inhibitor against NF-κB, could restore fulvestrant-mediated suppression of growth in breast cancer cell lines [61].